Vincerx Pharma Stock Net Income
| VINC Stock | USD 0.69 0 0.68% |
Vincerx Pharma fundamentals help investors to digest information that contributes to Vincerx Pharma's financial success or failures. It also enables traders to predict the movement of Vincerx Stock. The fundamental analysis module provides a way to measure Vincerx Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vincerx Pharma stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -58.8 M | -55.9 M | |
| Net Loss | -40.2 M | -42.2 M | |
| Net Loss | -48.9 M | -51.3 M | |
| Net Loss | (1.89) | (1.98) | |
| Net Income Per E B T | 1.01 | 0.84 |
Vincerx | Net Income |
Vincerx Pharma Company Net Income Analysis
Vincerx Pharma's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Vincerx Pharma Net Income | (40.16 M) |
Most of Vincerx Pharma's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vincerx Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Vincerx Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Vincerx Pharma is extremely important. It helps to project a fair market value of Vincerx Stock properly, considering its historical fundamentals such as Net Income. Since Vincerx Pharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vincerx Pharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vincerx Pharma's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Vincerx Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Vincerx Pharma reported net income of (40.16 Million). This is 111.77% lower than that of the Biotechnology sector and 157.33% lower than that of the Health Care industry. The net income for all United States stocks is 107.03% higher than that of the company.
Vincerx Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vincerx Pharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vincerx Pharma could also be used in its relative valuation, which is a method of valuing Vincerx Pharma by comparing valuation metrics of similar companies.Vincerx Pharma is currently under evaluation in net income category among related companies.
Vincerx Pharma Institutional Holders
Institutional Holdings refers to the ownership stake in Vincerx Pharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vincerx Pharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vincerx Pharma's value.| Shares | Renaissance Technologies Corp | 2023-12-31 | 176 K | Geode Capital Management, Llc | 2023-12-31 | 154 K | Walleye Trading Advisors, Llc | 2023-12-31 | 115 K | Sio Capital Management, Llc | 2023-12-31 | 102 K | Blackrock Inc | 2023-12-31 | 64.3 K | State Street Corporation | 2023-12-31 | 43.1 K | T. Rowe Price Associates, Inc. | 2024-03-31 | 30 K | Millennium Management Llc | 2024-03-31 | 25.9 K | Northern Trust Corp | 2023-12-31 | 25.6 K | Goldman Sachs Group Inc | 2023-12-31 | 3.4 M | Sage Rhino Capital Llc | 2024-03-31 | 1.7 M |
Vincerx Fundamentals
| Return On Equity | -1.36 | ||||
| Return On Asset | -0.69 | ||||
| Current Valuation | 6.09 M | ||||
| Shares Outstanding | 29.53 M | ||||
| Shares Owned By Insiders | 19.69 % | ||||
| Shares Owned By Institutions | 35.74 % | ||||
| Number Of Shares Shorted | 1.03 M | ||||
| Price To Book | 1.87 X | ||||
| EBITDA | (41.69 M) | ||||
| Net Income | (40.16 M) | ||||
| Cash And Equivalents | 80.86 M | ||||
| Cash Per Share | 3.82 X | ||||
| Total Debt | 2.5 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 7.88 X | ||||
| Book Value Per Share | 0.52 X | ||||
| Cash Flow From Operations | (40.45 M) | ||||
| Short Ratio | 0.63 X | ||||
| Earnings Per Share | (1.89) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 42 | ||||
| Beta | 1.2 | ||||
| Market Capitalization | 20.4 M | ||||
| Total Asset | 18.22 M | ||||
| Retained Earnings | (159.11 M) | ||||
| Working Capital | 9.13 M | ||||
| Net Asset | 18.22 M |
About Vincerx Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vincerx Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vincerx Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vincerx Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vincerx Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vincerx Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vincerx Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vincerx Pharma Stock:Check out Vincerx Pharma Piotroski F Score and Vincerx Pharma Altman Z Score analysis. For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Vincerx Stock analysis
When running Vincerx Pharma's price analysis, check to measure Vincerx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vincerx Pharma is operating at the current time. Most of Vincerx Pharma's value examination focuses on studying past and present price action to predict the probability of Vincerx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vincerx Pharma's price. Additionally, you may evaluate how the addition of Vincerx Pharma to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Vincerx Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vincerx Pharma. If investors know Vincerx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vincerx Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.89) | Return On Assets (0.69) | Return On Equity (1.36) |
The market value of Vincerx Pharma is measured differently than its book value, which is the value of Vincerx that is recorded on the company's balance sheet. Investors also form their own opinion of Vincerx Pharma's value that differs from its market value or its book value, called intrinsic value, which is Vincerx Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vincerx Pharma's market value can be influenced by many factors that don't directly affect Vincerx Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vincerx Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vincerx Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vincerx Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.